NASDAQ: CRISCuris Inc Stock Ownership - Who owns Curis?
Insider buying vs selling
Have Curis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kenneth I. Kaitin | Director | 2026-03-31 | 10,000 | $0.55 | $5.49kBuy |
CRIS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRIS insiders and whales buy or sell their stock.
CRIS Shareholders
What type of owners hold Curis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aurigene Discovery Technologies Ltd | 1,307.53% | 27,328,464 | $40.72M | Insider |
| Bvf Partners L P | 966.94% | 20,209,768 | $30.11M | Insider |
| Ra Capital Management LP | 299.06% | 6,250,564 | $9.31M | Insider |
| James R. McNab | 93.14% | 1,946,638 | $2.90M | Insider |
| Ali Phd Fattaey | 15.41% | 322,140 | $479.99k | Insider |
| Daniel R. Passeri | 10.13% | 211,798 | $315.58k | Insider |
| David Tuck | 8.11% | 169,424 | $252.44k | Insider |
| Douglas Melton | 7.82% | 163,499 | $243.61k | Insider |
| James E. Dentzer | 7.12% | 148,730 | $221.61k | Insider |
| James R. Tobin | 6.93% | 144,921 | $215.93k | Insider |
CRIS vs Biotech Stocks
Curis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.